Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein-Jr phase 3 dose-exposure-response evaluation - Young, G; Lensing, A WA; Monagle, P; EINSTEIN-Jr. Phase 3 Investigators (J Thromb Haemost, 2020)